In the afternoon of the Food Packaging Forum’s annual workshop, speakers discuss changing narratives to make information actionable, share behind-the-scenes of a reuse system running for over 80 years; panels discuss visions, obstacles for a sustainable food system
Review on low-dose effects of hormones and EDCs
In-depth review of low-dose effects of hormones and endocrine disrupting chemicals and their implications for risk assessment
EFSA changed abstract of its BPA risk assessment
Abstract of EFSA’s risk assessment now acknowledges low health concern associated with aggregate exposure to BPA
EFSA: Strategy 2020
Management board adopts EFSA’s strategy 2020; main objectives include engagement of public and stakeholders in scientific assessment; policy update on EFSA’s independence planned; CEF and ANS Panels to be replaced by new panels in 2018
EFSA identifies gaps in risk assessment guidance
Scientific Committee recommends new EFSA guidance on the use of the weight of evidence approach and biological relevance in toxicology
EFSA phthalates working group: 8th meeting
EFSA’s CEP Panel working group on phthalates supports EFSA webinar on the risk assessment of phthalates used in plastic food contact materials; webinar now available to watch online
FPF comments on EFSA’s phthalates prioritization strategy
Food Packaging Forum (FPF) finds that the European Food Safety Authority’s (EFSA) planned approach lacks clear recommendation for removing known hazardous chemicals from food contact materials; prioritization of food contact chemicals of concern should be based on hazard properties in alignment with the EU Chemicals Strategy for Sustainability
EFSA seeks feedback on communicating uncertainty
EFSA publishes draft guidance on communication of uncertainty in scientific assessments; public consultation open until June 24, 2018
EFSA evaluates new recycling processes for PP and PET
EFSA’s CEF panel publishes two new scientific opinions on recycling processes, materials considered safe for food contact
CLARITY-BPA webinars: Key messages
Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects